1. Pink Sheet
  2. >>Geography
  3. >>North America

FDA's Initial IND Warnings For CBD Supplements Could Ignite Regulatory Test

 
• By Malcolm Spicer

FDA's warnings that supplements containing cannabis-derived ingredients are adulterated comes 10 months year after it stated the policy and a year after submitting other warnings that stopped short of saying the ingredients are noncompliant.

FDA warnings that dietary supplements containing cannabis extract cannabidiol are adulterated because the substance is being studied as an investigational new drug leave open a door for firms to convince the agency that the ingredient's use in supplements pre-dates the INDs.

The warning letters published Feb. 10 to six firms making disease claims for their products are the agency's first since its

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from United States

More from North America